Inventor · disambiguated record
Harold Victor Taylor
Also filed as: TAYLOR HAROLD · TAYLOR HAROLD V · TAYLOR HAROLD VICTOR
14 granted patents·7 pending applications·165 citations·filing 2005–2024
93Inventor score
Files withMERZ PHARMA GMBH & CO KGAA15TAYLOR HAROLD VICTOR2BURGER MARKUS1MANDER GERD J1PFEIL MICHAEL1
Top patents by PatentIndex Score
21 records- 0196US10105421B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Oct 23, 2018·19 cites·17 claims
- 0295US8372645B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2010·Granted Feb 12, 2013·24 cites·7 claims
- 0395US7879341B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2005·Granted Feb 1, 2011·34 cites·22 claims
- 0494US9220783B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2015·Granted Dec 29, 2015·14 cites·6 claims
- 0592US9050367B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2013·Granted Jun 9, 2015·13 cites·5 claims
- 0691US8652489B2Therapeutic composition with a botulinum neurotoxinMERZ PHARMA GMBH & CO KGAA·Filed 2013·Granted Feb 18, 2014·11 cites·8 claims
- 0790US9173944B2Formulation suitable for stabilizing proteins, which is free of mammalian excipientsTAYLOR HAROLD VICTOR·Filed 2011·Granted Nov 3, 2015·15 cites·15 claims
- 0885US9198856B2Formulation for stabilizing proteins, which is free of mammalian excipientBURGER MARKUS·Filed 2010·Granted Dec 1, 2015·16 cites·9 claims
- 0982US9447175B2Means and methods for manufacturing highly pure neurotoxinPFEIL MICHAEL·Filed 2010·Granted Sep 20, 2016·10 cites·5 claims
- 1077US9310386B2In vitro assay for quantifying clostridial neurotoxin activityWILK THOMAS·Filed 2011·Granted Apr 12, 2016·6 cites·14 claims
- 1177US8841080B2System for determining unprocessed and partially processed neurotoxin type ATAYLOR HAROLD VICTOR·Filed 2010·Granted Sep 23, 2014·3 cites·11 claims
- 1270US2024238393A1Composition comprising botulinum toxinMERZ PHARMA GMBH & CO KGAA·Filed 2024·Application pending·0 cites
- 1368US2009010965A1Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxinMERZ PHARMA GMBH & CO KGAA·Filed 2008·Application pending·0 cites
- 1464US2025152682A1Liquid botulinum toxin formulation and use thereofMERZ PHARMA GMBH & CO KGAA·Filed 2023·Application pending·0 cites
- 1564US2025161186A1Liquid botulinum toxin formulation and use thereofMERZ PHARMA GMBH & CO KGAA·Filed 2023·Application pending·0 cites
- 1661US11969461B2Composition comprising botulinum toxinMERZ PHARMA GMBH & CO KGAA·Filed 2017·Granted Apr 30, 2024·0 cites·13 claims
- 1758US9213026B2System for determining unprocessed and partially processed neurotoxin type AMERZ PHARMA GMBH & CO KGAA·Filed 2014·Granted Dec 15, 2015·0 cites·3 claims
- 1849US9963502B2Antibody that specifically binds partially processed or unprocessed neurotoxin polypeptidesMERZ PHARMA GMBH & CO KGAA·Filed 2016·Granted May 8, 2018·0 cites·2 claims
- 1942US2006067950A1Clostridial neurotoxins for use in wound healingMERZ PHARMA GMBH & CO KGAA·Filed 2005·Application pending·0 cites
- 2041US2016184413A1Formulation for stabilizing proteins, which is free of mammalian excipientMERZ PHARMA GMBH & CO KGAA·Filed 2015·Application pending·0 cites
- 2137US2012282647A1Assay for quantifying clostridial neurotoxinMANDER GERD J·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →